When to Seek Second Opinion In Cancer ?
A second opinion in cancer care is most valuable when a patient is newly diagnosed, when treatment decisions involve major […]
Treatment Strategy & Second Opinions
Precision Oncology
When Immunotherapy Works Even With Low PD-L1 Expression
While PD-L1 testing is widely used to guide immunotherapy decisions, a low or negative PD-L1 result does not necessarily mean
Precision Oncology
The Role of PD-L1 Testing Before Starting Immunotherapy
PD-L1 testing is an important biomarker assessment used to guide the use of immunotherapy in several cancers, particularly lung cancer
Disease-Specific Deep Dives
Molecular Subtypes of Breast Cancer and Their Treatment Implications
Molecular subtypes of Breast cancer is biologically classified using ER, PR, and HER2 status (and sometimes proliferation/genomic assays). These markers
Cancer Genetics & Hereditary Risk
When Should Patients Undergo Genetic Testing for Cancer Risk?
Genetic testing for cancer risk should be considered when personal or family history suggests a hereditary cancer syndrome. This includes
Precision Oncology
What Is Biomarker-Driven Therapy in Modern Oncology?
Biomarker-driven therapy is a precision oncology approach where cancer treatment is selected based on specific molecular characteristics of a tumor
Geriatric & AYA Oncology
Individualizing Cancer Treatment in the Elderly and Young Adults: A Structured Approach to Geriatric & AYA Oncology
Cancer treatment should not be determined by age alone. Elderly patients require physiologic assessment beyond chronological age, while adolescents and
Disease-Specific Deep Dives
Molecular Subtypes Across Common Cancers: Why Biology Matters More Than Stage
Cancer stage describes where the disease has spread. Molecular subtype explains how the cancer behaves. In modern oncology, treatment decisions
Treatment Strategy & Second Opinions
How Structured Second Opinions Improve Cancer Treatment Decisions
A structured second opinion in oncology is a systematic re-evaluation of diagnosis, staging, pathology, molecular data, and treatment sequencing. It
Cancer Genetics & Hereditary Risk
When and Why Genetic Testing Matters in Cancer Treatment and Prevention
Genetic testing in cancer evaluates inherited (germline) mutations that may influence both treatment decisions and long-term risk assessment. It helps